@article{article, title  = {{Zanubrutinib versus acalabrutinib indirect treatment comparison in relapsed or refractory mantle cell lymphoma}},

 url = {{}},

 year = {{2025}},

 month = {{9}},

 author = {{Shah B and Challagulla S and Xu S and Williams R and Ren S and Srivastava T and Gautam R and Yang K and Saba NS and Tam CS}},

 doi = {{10.1080/10428194.2025.2541911}},

 journal = {{Leukemia and Lymphoma}},

 note = {{Accessed on 2025/09/16}}}